Virus Updates: Oxford Vaccine Trial Begins; Military Academies Resume Classes

The University of Wisconsin is one of dozens of test sites in the U.S. for the vaccine candidate, made by AstraZeneca in partnership with the U.K.’s University of Oxford. Tuesday’s trial will mark the start of the third phase 3 trial in the U.S. for a COVID-19 vaccine, following Moderna and Pfizer.